Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-008208
Filing Date
2012-02-07
Accepted
2012-02-07 17:23:40
Documents
1
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 4083
  Complete submission text file 0001209191-12-008208.txt   5705
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612
PARKER H STEWART (Reporting) CIK: 0001217456 (see all company filings)

State of Incorp.: WA | Fiscal Year End: 1231
Type: 5 | Act: 34 | File No.: 033-80623 | Film No.: 12578815
SIC: 2836 Biological Products, (No Diagnostic Substances)